P. Birrer - Concepedia

Author

P. Birrer

University of Bern

Also Known As

Birrer, Peter, P Birrer, P. Birrer, Peter Birrer, Yankaskas, James R.

Publications

Citations

H-Index

Concepts

All Affiliations

University of Bern University Hospital of Bern National Institutes of Health National Heart Lung and Blood Institute Institute of Medical Microbiology and Hygiene

About

P. Birrer is an author at University of Bern specializing in medicine, pulmonary disease, and asthma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	2.6K
2	Immunology	5	5	900
3	Allergy	3	3	598
4	Public Health	1	1	33
5	Biomolecular Engineering	1	1	205

P. Birrer

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients Dieter Worlitzsch, Robert Tarran, Martina Ulrich, Journal of Clinical Investigation	2002	1.1K
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients Dieter Worlitzsch, Robert Tarran, Martina Ulrich, Journal of Clinical Investigation Antimicrobial SusceptibilityInflammatory Lung DiseaseAntibioticsLung InflammationLocal Hypoxia	2002	897
Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. P. Birrer, Noel G. McElvaney, A Rüdeberg, American Journal of Respiratory and Critical Care Medicine AsthmaInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationImmunology	1994	381
Aerosol α1 -antitrypsin treatment for cystic fibrosis Noel G. McElvaney, Richard C. Hubbard, P. Birrer, The Lancet MedicinePulmonary PharmacologyPulmonary FibrosisPulmonary MedicinePharmacology	1991	320
Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. Noel G. McElvaney, Hidenori Nakamura, P. Birrer, Journal of Clinical Investigation InflammationAsthmaCytokineInflammatory Lung DiseaseAutoimmune Disease	1992	297
A Preliminary Study of Aerosolized Recombinant Human Deoxyribonuclease I in the Treatment of Cystic Fibrosis Richard C. Hubbard, Noel G. McElvaney, P. Birrer, New England Journal of Medicine Inflammatory Lung DiseaseAdvanced Lung DiseaseGeneticsPulmonary Alveolar ProteinosisPathology	1992	205
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients Dieter Worlitzsch, Robert Tarran, Martina Ulrich, Journal of Clinical Investigation Antimicrobial SusceptibilityInflammatory Lung DiseaseAntibioticsLung InflammationLocal Hypoxia	2002	160
Pulmonary surfactant in cystic fibrosis Matthias Griese, P. Birrer, Asli Karsli Demirsoy European Respiratory Journal InflammationAsthmaPulmonary SurfactantLung DepositionLung Inflammation	1997	138
Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis Christina von Bredow, P. Birrer, Matthias Griese European Respiratory Journal	2001	70
Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid Adrian Gillissen, P. Birrer, Noel G. McElvaney, Journal of Applied Physiology AsthmaInflammatory Lung DiseaseLung InflammationLipid PeroxidationImmunology	1993	54

Page 1